The therapeutic effect of ribavirin plus pegylated interferon in chronic hepatitis B and C

被引：0
|
作者：
Chien, Rong-Nan
Hu, Ching-Chih
Sheen, I-Shyan
Liaw, Yun-Fan
Yen, Cho-Li
Chang, Jia-Jang
机构：
[1] Chang Gung Mem Hosp, Liver Res Unit, Chilung, Taiwan
[2] Chang Gung Mem Hosp & Univ, Liver Res Unit, Taipei, Taiwan
来源：
HEPATOLOGY | 2006年 / 44卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
402
引用
收藏
页码：341A / 341A
页数：1
相关论文
共 50 条
  • [21] Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
    Seo, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Ohtani, Aya
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Saijo, Yuka
    Kim, Ke Ih
    Imoto, Susumu
    Kim, Chi Wan
    Yano, Yoshihiko
    Kudo, Masatoshi
    Hayashi, Yoshitake
    DIGESTIVE DISEASES, 2017, 35 (06) : 541 - 547
  • [22] Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis
    Camma, Calogero
    Cabibbo, Giuseppe
    Bronte, Fabrizio
    Enea, Marco
    Licata, Anna
    Attanasio, Massimo
    Andriulli, Angelo
    Craxi, Antonio
    JOURNAL OF HEPATOLOGY, 2009, 51 (04) : 675 - 681
  • [23] Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients
    Lee, S. Y.
    Lee, S.
    Ko, K. S.
    Kim, I. H.
    Kim, S. H.
    Kim, S. W.
    Lee, S. O.
    Lee, S. T.
    Kim, D. G.
    Choi, C. S.
    Cho, E. Y.
    Kim, H. C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
  • [24] THERAPEUTIC RESPONSE TO PEG-INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C
    Harja-Alexa, Ioana-Alina
    Luca, Mihaela-Catalina
    Manciuc, Carmen Doina
    Vata, A.
    Badescu, Aida
    Hurmuzache, M. E.
    Ciocan, Alexandra Mirela
    Hunea, Ioana Maria
    Trofin, Felicia
    Iancu, Luminita Smaranda
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2019, 123 (04): : 615 - 622
  • [25] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Irit Rosen
    Michal Kori
    Orly Eshach Adiv
    Baruch Yerushalmi
    Nataly Zion
    Ron Shaoul
    World Journal of Gastroenterology, 2013, (07) : 1098 - 1103
  • [26] VISCERAL ADIPOSITY INFLUENCES THE ANTIVIRAL EFFECT OF PEGYLATED INTERFERON PLUS RIBAVIRIN TREATMENT FOR REFRACTORY CHRONIC HEPATITIS C
    Mizuta, Toshihiko
    Kawaguchi, Yasunori
    Eguchi, Yuichiro
    Takahashi, Hirokazu
    Iwane, Shinji
    Kuwashiro, Takuya
    Oeda, Satoshi
    Isoda, Hiroshi
    Ozaki, Iwata
    HEPATOLOGY, 2010, 52 (04) : 766A - 767A
  • [27] Chronic hepatitis C: Retreatment of pegylated interferon/ribavirin nonresponders
    Cardoso, Helder
    Vale, Ana Horta
    Mendes, Margarida
    Bastos, Pedro
    Machado, Artur
    Santos, Carlos
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S192 - S193
  • [28] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [29] Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Carvalho-Filho, Roberto J.
    Dalgard, Olav
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 1 - 13
  • [30] Ribavirin plus interferon versus interferon for chronic hepatitis C
    Brok, Jesper
    Gluud, Lise Lotte
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
12345